Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - SYNAGEVA BIOPHARMA CORP | d856934dex312.htm |
EX-31.1 - EX-31.1 - SYNAGEVA BIOPHARMA CORP | d856934dex311.htm |
EX-32.1 - EX-32.1 - SYNAGEVA BIOPHARMA CORP | d856934dex321.htm |
EX-23.1 - EX-23.1 - SYNAGEVA BIOPHARMA CORP | d856934dex231.htm |
EX-10.19 - EX-10.19 - SYNAGEVA BIOPHARMA CORP | d856934dex1019.htm |
EXCEL - IDEA: XBRL DOCUMENT - SYNAGEVA BIOPHARMA CORP | Financial_Report.xls |
10-K - FORM 10-K - SYNAGEVA BIOPHARMA CORP | d856934d10k.htm |
Exhibit 21.1
Subsidiary |
Jurisdiction of Organization | |
Abbey BioPharma Corp. |
Delaware | |
Synageva BioPharma Ltd |
United Kingdom | |
Synageva BioPharma B.V. |
Netherlands | |
Synageva BioPharma Germany GmbH |
Germany | |
Synageva BioPharma GmbH |
Switzerland | |
Synageva BioPharma Japan KK |
Japan | |
Synageva BioPharma Luxembourg S.a.r.l. |
Luxembourg | |
Synageva BioPharma SAS |
France | |
Synageva BioPharma S de RL de CV |
Mexico | |
Synageva BioPharma S.L. |
Spain | |
Synageva BioPharma S.R.L. |
Italy | |
Synageva Participações Limitada |
Brazil | |
Synageva Securities Corp. |
Massachusetts |